Scolaris Content Display Scolaris Content Display

Medicinal herbs for esophageal cancer

This is not the most recent version

References

Additional references

Blot 1993

Blot WJ, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993;270(11):1320.

Broitman 1983

Broitman SA, Vitale JJ. Ethanolic beverage consumption, cigarette smoking,nutritional status, and digestive tract cancers. Semin Oncol 1983;10(3):322‐329.

Carter 1992

Carter R, Smith JS, Anderson JR. Laser recanalization versus endoscopic intubation in the palliation of malignant dysphagia: a randomized prospective study. Br J Surg 1992;79(11):1167‐70.

Chen 2003

Chen HH, Zhou HJ, Fang X. Inhibition of human cancer cell line growth and human umbilical vein endothelial cell angiogenesis by artemisinin derivatives in vitro.. Pharmacol Res. 2003;48(3):231‐6.

Chrystal 2002

Chrystal K, Allan S, Forgeson G, Isaacs R. Chrystal K, Allan S, Forgeson G, Isaacs R.. N Z Med J 2002;116(1168):U296.

Clark 1994

Clark GW, Peters JH, Ireland AP, et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy of adenocarcinoma. Ann Thorac Surg 1994;58(3):646‐54.

Clarke 2000

Clarke M, Oxman AD, editors. Optimal search strategy for RCTs.. Reviewers' Handbook 4.1.5 [updated April 2002] 2002:appendix 5c. 126‐7.

Cohen 1960

Cohen J. A coefficient of agreement for nominal scales. Educational and Psychological Measurement 1960;20:37‐46.

Cooper 1999

Cooper JS, Guo MD, Herskovic A. Chemoradiotherapy of locally advanced esophageal cancer: long‐term follow‐up of a prospective randomized trial. JAMA 1999;281(17):1623‐7.

Du 1998

Du Huazhen, Gao Xinpin. effections of membranous milkvetch root on immune function of patients with esophageal cancer during surgery. Chinese Journal of Intergrated Traditional and Western Medicine on Digestion 1998;6(3):136‐139.

Entwistle 2002

Entwistle JW, Goldberg M. Multimodality therapy for resectable cancer of the thoracic esophagus. Ann Thorac Surg 2002;73(3):1009‐15.

Goldminc 1993

Goldminc M, Maddern G, Le Prise E. Oesophagectomy by a transhiatal approach or thoracotomy: a prospective randomized trial. Br J Surg 1993;80(3):367‐70.

Herskovic 1992

Herskovic A, Martz K, al‐Sarraf M. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992;326(24):1593‐8.

Hilsden 1999

Hilsden RJ, Meddings JB, Verhoef MJ. Complementary and alternative medicine use by patients with inflammatory bowel disease: An Internet survey. Can J Gastroenterol 1999;13(4):327‐32.

Homs 2003

Homs MY, Eijkenboom WM, Coen VL, Haringsma J, Blankenstein M, Kuipers EJ, Siersema PD. High dose rate brachytherapy for the palliation of malignant dysphagia. Radiother Oncol 2003;66(3):327‐32.

Jia 2001

Jia Zhenhuo, Wang Xiaoyang. liuweidihuang pilula for preventing peripheral circulatory blood declines after radiation therapy for esophageal cancer (54 cases reported). JTCM 2001;42(7):402.

Juni 2001

Juni P, Altman DG, Egger M. Assessing the quality of controlled clinical trials. British Medical Journal 2001, (323):42‐6.

Kirby 1994

Kirby TJ, Rice TW. The epidemiology of esophageal carcinoma. The changing face of a disease. Chest Surg Clin N Am 1994;4(2):217‐25.

Knyrim 1993

Knyrim K, Wagner HJ, Bethge N. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993;329(18):1302‐7.

Lam 2000

Lam AKY. Molecular biology of esophageal squamous cell carcinoma. Critical Reviews in Oncology/Hematology 2000;33(2):71‐90.

Lampert 2002

Lampert N, Xu Y. Chinese herbal nephropathy. Lancet 2002;359(9308):796‐7.

Lord 2001

Lord GM, Cook T, Arlt VM, Schmeiser HH, Williams G, Pusey CD. Urothelial malignant disease and Chinese herbal nephropathy. Lancet 2001;358(9292):1515‐6.

Mandard 2000

Mandarda AM, Hainautb P, Hollsteinc M. Genetic steps in the development of squamous cell carcinoma of the esophagus. Mutation Research/Reviews in Mutation Research 2000;462(2‐3):335‐342.

Messmann 2001

Messmann H. Squamous cell cancer of the oesophagus. Best Practice & Research Clinical Gastroenterology 2001;15(2):249‐265.

Nishihira 1993

Nishihira T, Hashimoto Y, et al. Molecular and cellular features of esophageal cancer cells. J Cancer Res Clin Oncol 1993;119(8):441‐449.

Nortier 2000

Nortier JL, Martinez MC, Schmeiser HH, Arlt VM, Bieler CA, Petein M, Depierreux MF, De Pauw L, Abramowicz D, Vereerstraeten P, Vanherweghem JL. Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med. 2000;342(23):1686‐92.

O'Byrne 2001

O'Byrne KJ, Dalgleish AG. Chronic immune activation and inflammation as the cause of malignancy. British Journal of Cancer 2001;85(4):473‐483.

Pera 2001

Pera M. Recent changes in the epidemiology of esophageal cancer. Surg Oncol 2001;10(3):81‐90.

Sammon 1998

Sammon AM. Protease inhibitors and carcinoma of the esophagus. Cancer 1998;83(3):405‐408.

Sarper 2003

Sarper A, Oz N, Cihangir C, Demircan A, Isin E. The efficacy of self‐expanding metal stents for palliation of malignant esophageal strictures and fistulas. Eur J Cardiothorac Surg 2003;23(5):794‐8.

Shi 2000

Shi Shuzhi, Cai Xiulian. clinical observation on effects of jinlong capsule combined chinese herbs for esophageal cancer on advanced stage (16 cases reported) clinical observation on effects of jinlong capsule combined chinese herbs for esophageal cancer on late stage (16 cases reported). Journal of Beijing of Chinese Traditional Medicine 2000;19(6):57‐60.

Shumay 2001

Shumay DM, Maskarinec G, Kakai H, Gotay CC. Why some cancer patients choose complementary and alternative medicine instead of conventional treatment. J Fam Pract. 2001; Vol. 50, issue 12:1067.

Steup 1996

Steup WH, DeLeyn P, Deneffe I, et al. Tumors of the esophagogastric junction: Long‐term survival in relation to the pattern of lymph node metastasis and a critical analysis of the accuracy or inaccuracy of pTNM classification.. J Thorac Cardiovasc Surg 1996;111(1):85‐94; discussion 94‐5.

Swanstrom 2002

Swanstrom LL. Minimally invasive surgical approaches to esophageal cancer. J Gastrointest Surg 2002;11(2):337‐50.

Teng 1999

Teng S, Karl R. Surgical Approaches to Esophageal Cancer. Cancer Control 1999;6(1):36‐42.

Tuyns 1979

Tuyns AG, Prquignot G. Esophageal Cancer and Alcohol Consumption:importance of type of beverage [Esophageal Cancer and Alcohol Consumption:importance of type of beverage]. Int J Cancer 1979;23:443‐447.

Victora 1987

Victora CG, Munoz N. Hot beverage and esophageal cancer in southern Brazil:a case‐control study. Int J Cancer 1987;39(6):710‐6.

Williamsom 1991

Williamsom WA, Ellis FH. Barrett' esophagus:prevalence and incidence of adenocarcinoma. Arch Intern Med 1991;151(11):2212‐16.

Wu 2001

Wu MT, Lee YC, Chen CJ. risk of betel chewing for oesophageal cancer in Taiwan. The British Journal of Cancer 2001;85(5):658‐660.

Wu 2003

Wu PC, Posner MC. The role of surgery in the management of oesophageal cancer. Lancet Oncol 2003;4(8):481‐8.

Ye 2002

Ye F, Xui L, Yi J, Zhang W, Zhang DY. Anticancer activity of Scutellaria baicalensis and its potential mechanism. J Altern Complement Med 2002;8(5):567‐72.

Zhou 1996

Zhou Junshun, Wang Yaozhi. chinese herbs combined local chemotherapy and microwave for esophageal cancer. Henan Journal of Traditional Chinese Medicine 1996;16(6):365.